J.-P. Bronowicki

1.4k total citations
27 papers, 796 citations indexed

About

J.-P. Bronowicki is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.-P. Bronowicki has authored 27 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.-P. Bronowicki's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). J.-P. Bronowicki is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). J.-P. Bronowicki collaborates with scholars based in France, United States and Japan. J.-P. Bronowicki's co-authors include Marc Bourlière, Xavier Forns, Sivi Ouwerkerk‐Mahadevan, Andrzej Horban, Jane Scott, Ed Gane, Ronald Kalmeijer, Guy De La Rosa, Ashley Brown and Oliver Lenz and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

J.-P. Bronowicki

26 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.-P. Bronowicki France	14	641	498	147	66	61	27	796
J.‐P. Bronowicki France	15	589 0.9×	465 0.9×	88 0.6×	69 1.0×	73 1.2×	31	731
Toshikazu Masumoto Japan	14	324 0.5×	346 0.7×	204 1.4×	67 1.0×	61 1.0×	39	799
Giada Pietrosi Italy	16	436 0.7×	498 1.0×	369 2.5×	25 0.4×	16 0.3×	40	882
Nicola Alessi Italy	11	421 0.7×	487 1.0×	78 0.5×	43 0.7×	51 0.8×	21	642
Soo Hyung Ryu South Korea	16	353 0.6×	329 0.7×	240 1.6×	55 0.8×	16 0.3×	57	800
Kyosuke Kaji Japan	14	235 0.4×	206 0.4×	151 1.0×	23 0.3×	48 0.8×	22	509
Valérie Bourcier France	14	875 1.4×	813 1.6×	207 1.4×	45 0.7×	14 0.2×	26	1.2k
Terasu Honma Japan	15	164 0.3×	224 0.4×	280 1.9×	60 0.9×	60 1.0×	75	652
Michael A. Heneghan United Kingdom	20	991 1.5×	868 1.7×	325 2.2×	13 0.2×	253 4.1×	26	1.2k
Mengfei Liu United States	9	257 0.4×	317 0.6×	131 0.9×	79 1.2×	17 0.3×	22	696

Countries citing papers authored by J.-P. Bronowicki

Since Specialization

Citations

This map shows the geographic impact of J.-P. Bronowicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Bronowicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Bronowicki more than expected).

Fields of papers citing papers by J.-P. Bronowicki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Bronowicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Bronowicki. The network helps show where J.-P. Bronowicki may publish in the future.

Co-authorship network of co-authors of J.-P. Bronowicki

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Bronowicki. A scholar is included among the top collaborators of J.-P. Bronowicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Bronowicki. J.-P. Bronowicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baère, Thierry de, Y. Rolland, J.-P. Bronowicki, et al.. (2020). Phase I/II Study Of Radiation Enhancing Hafnium Oxide Nanoparticles NBTXR3 Activated by SBRT in HCC and Liver Metastases Patients. International Journal of Radiation Oncology*Biology*Physics. 108(3). e577–e578. 1 indexed citations

Merle, Philippe, Philippe Camus, Armand Abergel, et al.. (2017). Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma. ESMO Open. 2(4). e000238–e000238. 36 indexed citations

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2017). Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort. World Journal of Gastroenterology. 23(14). 2545–2545. 20 indexed citations

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2017). NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization. European Journal of Gastroenterology & Hepatology. 29(6). 706–715. 7 indexed citations

Bruix, Jordi, Philippe Merle, Alessandro Granito, et al.. (2016). Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trial. Annals of Oncology. 27. vi564–vi564. 8 indexed citations

Bruix, Jordi, Philippe Merle, Alessandro Granito, et al.. (2016). LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial. Annals of Oncology. 27. ii140–ii140. 27 indexed citations

Adhoute, Xavier, Guillaume Pénaranda, Jean‐Luc Raoul, et al.. (2014). Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process. Journal of Hepatology. 62(4). 855–862. 117 indexed citations

Forns, Xavier, Eric Lawitz, Stefan Zeuzem, et al.. (2014). Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial. Gastroenterology. 146(7). 1669–1679.e3. 187 indexed citations

Petit, Jean Michel, Samia Hamza, Fabien Rollot, et al.. (2013). Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis. Acta Diabetologica. 51(3). 455–60. 21 indexed citations

10.

Bourlière, Marc, et al.. (2013). How to optimize HCV therapy in genotype 1 patients with cirrhosis. Liver International. 33(s1). 46–55. 23 indexed citations

11.

Nguyen, Thu Anh, Aude Bressenot, J.-P. Bronowicki, et al.. (2009). Contrast-Enhanced Ultrasonography in Patients With Glycogen Storage Disease Type Ia and Adenomas. Journal of Ultrasound in Medicine. 28(4). 497–505. 4 indexed citations

12.

Lalonde, Robert, et al.. (2007). Effects of a B-vitamin-deficient diet on exploratory activity, motor coordination, and spatial learning in young adult Balb/c mice. Brain Research. 1188. 122–131. 20 indexed citations

13.

Couzigou, Patrice, Marc Bourlière, J.-P. Bronowicki, et al.. (2006). CA 69-Ajoût d’interféron-gamma 1b (IFN-gamma 1b) 16 semaines après l’initiation d’un traitement par PEG-interféron alpha-2a (IFN alpha-2a)/ ribavirine (RIBA) chez des malades porteurs d’une hépatite chronique C et non répondeurs à une première ligne de traitement, ESSAI ANRS HC16 GAMMATRI. Gastroentérologie Clinique et Biologique. 30(8-9). 1083–1083. 1 indexed citations

14.

Abergel, Armand, Claude Darcha, Michèle Chevallier, et al.. (2004). Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis. European Journal of Gastroenterology & Hepatology. 16(11). 1219–1227. 26 indexed citations

15.

Bronowicki, J.-P., Denis Ouzan, Tarik Asselah, et al.. (2003). 187 Efficacy and safety of 22 weeks of maintenance therapy with peginterferon alfa-2A (40KD) (PEGASYS™) alone versus peginterferon alfa-2A (40KD) plus ribavirin(COPEGUS™) in naive patients with chronic hepatitis C and genotype 1 who responded to a 24-week course of peginterferon alfa-2A (40KD) plus ribavirin: an open, multicenter, randomized trial. Hepatology. 38. 244–245. 5 indexed citations

16.

Calès, Paul, Claude Masliah, Brigitte Bernard, et al.. (2001). Early Administration of Vapreotide for Variceal Bleeding in Patients with Cirrhosis. New England Journal of Medicine. 344(1). 23–28. 144 indexed citations

17.

Bronowicki, J.-P., et al.. (1998). [Role of sex steroids and their receptors in the pathophysiology of hepatocellular carcinoma].. PubMed. 22(1). 73–86. 9 indexed citations

18.

Aimone‐Gastin, Isabelle, et al.. (1997). Prospective evaluation of protein bound vitamin B ₁₂ (cobalamin) malabsorption in the elderly using trout flesh labelled in vivo with ⁵⁷ Co-cobalamin. Gut. 41(4). 475–479. 20 indexed citations

19.

Guéant, Jean‐Louis, Isabelle Aimone‐Gastin, Hanitra Rabesona, et al.. (1997). Autoantibodies in pernicious anemia type I patients recognize sequence 251-256 in human intrinsic factor.. PubMed. 109(5). 462–9. 15 indexed citations

20.

Hudziak, Hervé, et al.. (1996). [Low-dose polyethylene glycol 4000: digestive effects. Randomized double-blind study in healthy subjects].. PubMed. 20(5). 418–23. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact